Company Search:
Advanced Search
Sponsored Links
Humanigen Inc Company Snapshot
Humanigen Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Humanigen Inc with three other companies in this sector in the United States: Vitro Diagnostics, Inc. (2013 sales of $34,868.00 ), Idera Pharmaceuticals, Inc. ($47,000.00 of which 100% was Novel Therapeutics), and Vericel Corp ($19,000.00 of which 100% was Autologous Cell Products).

Sales Analysis.
  Stock Performance Chart for Humanigen Inc
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): .43
(Figures in U.S. Dollars)
1 Week -21.8%   13 Weeks -38.6%  
4 Weeks -50.6%   52 Weeks -39.5%  
Humanigen Inc Key Data:
  Ticker: HGEN Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2013 Sales 44,000
(Year Ending Jan 2014).
Employees: 17
  Currency: U.S. Dollars Market Cap: 48,495,566
  Fiscal Yr Ends: December Shares Outstanding: 112,780,386
  Share Type: Common Closely Held Shares: 100,589,964
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.